Carlisle Companies, Inc. (CSL) is a publicly traded Industrials sector company. As of October 21, 2026, CSL trades at $339.79 with a market cap of $13.12B and a P/E ratio of 18.26. CSL moved +2.82% today. Year to date, CSL is +3.45%; over the trailing twelve months it is +3.18%. Its 52-week range spans $293.43 to $435.92. Analyst consensus is buy with an average price target of $430.20. Rallies surfaces CSL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Australia's CSL names GSK exec Deborah Waterhouse as next CEO: CSL named ViiV Healthcare CEO Deborah Waterhouse as its next chief executive and managing director, effective February 1, 2027. Interim CEO Gordon Naylor will remain in the role until then and return to the board as a non-executive director.
| Metric | Value |
|---|---|
| Price | $339.79 |
| Market Cap | $13.12B |
| P/E Ratio | 18.26 |
| EPS | $17.58 |
| Dividend Yield | 1.25% |
| 52-Week High | $435.92 |
| 52-Week Low | $293.43 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $5.10B |
| Net Income | $724.50M |
| Gross Margin | 35.26% |
7 analysts cover CSL: 0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $430.20.